Apolipoprotein A-IV levels and phenotype distribution in NIDDM

Diabetes Care

Volumn 17, Issue 8, 1994, Pages 810-817

  Vergès, Bruno L ^a   Vaillant, Genevieve ^a   Goux, Alain ^a   Lagrost, Laurent ^a   Brun, Jhan M ^a   Gambert, Philippe ^a  

^a HÔPITAL DU BOCAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A4; FATTY ACID; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CORONARY RISK; DRUG BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE;

EID: 0028030666     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.17.8.810     Document Type: Article

References (33)

1. Howard BV: Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28:613-628, 1987
2. Reaven GM: Abnormal lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Am J Med 83 (Suppl. 3A): 31-40, 1987
3. Taskinen MR, Harno K, Nikkila EA: Serum lipids and lipoproteins in type 2 diabetes. Acta Endocrinol Suppl 262:95-99, 1984
4. Farnier M, Verges B, Gambert Ph, Vaillant-Piard G, Bidan Y, Brun JM: High density lipoprotein distribution in type 2 (non-insulin-dependent) diabetes. Diabetologia 29:235A-336A, 1986
5. Ulermann G, Beisiegel V: Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicroms and free in plasma: isolation and quantification. Eur J Biochem 99:333-343, 1979
6. Green PH, Glickman RM, Saudek CD, Blum CB, Tall AR: Human intestinal lipoproteins: studies in chyluric subjects. J Clin Invest 64:233-342, 1979
7. Green PH, Glickman RM, Riley JW, Quinet E: Human apolipoprotein A-IV: intestinal original and distribution in plasma. J Clin Invest 65:911-919, 1980
8. Weinberg RB, Scanu AM: Isolation and characterization of human apolipoprotein A-IV from lipoprotein depleted serum. J Lipid Res 24:52-59, 1983
9. Goldberg IJ, Scheraldi CA, Yacoub LK, Saxena U, Bisgaier CL: Lipoprotein apoC-II activation of lipoprotein lipase: modulation by apolipoprotein A-IV. J Biol Chem 265:4266-4272, 1990
10. Steinmetz A, Utermann G: Activation of lecithin:cholesterol acyl transferase by human apolipoprotein A-IV. J Biol Chem 260:2258-2264, 1985
11. Chen CH, Albers JJ: Activation of lecithin: cholesterol acyl transferase by apolipoproteins E-2, E-3 and A-IV isolated from human plasma. Biochim Biophys Acta 836:279-285, 1985
12. Savion N, Gamliel A: Binding of apolipoprotein A-I and apolipoprotein A-IV to cultured bovine aortic endothelial cells. Arteriosclerosis 8:178-186, 1988
13. Dvorin E, Gorder NL, Benson DM, Gotto Jr AM: Apolipoprotein A-IV: a determinant for binding and uptake of high density lipoproteins by rat hepatocytes. J Biol Chem 261:15714-15718, 1986
14. Weinberg RB, Patton CS: Binding of human apolipoprotein A-IV to human hepatocellular plasma membranes. Biochim Biophys Acta 1044:255-261, 1990
15. Stein O, Stein Y, Lefevre M, Roheim PS: The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from another analog of phosphatidylcholine. Biochim Biophys Acta 878:7-13, 1986
16. Steinmetz A, Barbaras R, Ghalim N, Clavey V, Fruchart J-C, Ailhaud G: Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem 265:7859-7863, 1990
17. Barter PJ, Rajaram OU, Chang LB, Rye KA, Gambert Ph, Lagrost L, Ehnholm C, Fidge NH: Isolation of a high density lipoprotein conversion factor from human plasma: a possible role of apolipoprotein A-IV as its activator. Biochem J 254:179-184, 1988
18. Lagrost L, Gambert P, Dangremont V, Athias A, Lallemant C: Role of cholesteryl ester transfer protein (CETP) in the HDL conversion process as evidenced by using anti-CETP monoclonal antibodies. J Lipid Res 31:1569-1575, 1990
19. Weinberg RB, Ibdah JA, Phillips MC: Adsorption of apolipoprotein A-IV to phospholipid monolayers spread at the air/water interface: a model for its labile binding to high density lipoproteins. J Biol Chem 267:8977-8983, 1992
20. Menzel HJ, Kövary PM, Assmann G: Apolipoprotein A-IV polymorphism in man. Hum Genet 62:349-352, 1982
21. Lohse P, Brewer HB Jr: Genetic polymorphism of apolipoprotein A-IV. Curr Opin Lipidol 2:90-95, 1991
22. Weinberg RB, Jordan MK, Steinmetz A: Distinctive structure and function of human apolipoprotein variant apoA-IV-2. J Biol Chem 265:18372-18378, 1990
23. Eichner JE, Kuller LH, Ferrell RE, Kamboh MI: Phenotypic effects of apolipoprotein structural variation on lipid profiles. II. Apolipoprotein A-IV and quantitative lipid measures in the healthy women study. Genet Epidemiol 6:493-499, 1989
24. Vergès B, Rader DJ, Schäfer JR, Lohse P, Zech LA, Gambert P, Steinmetz A, Brewer Jr HB: In vivo catabolism of apoA-IV-1 and apoA-IV-2 in normal and hypertriglyceridemic subjects. Circulation 86 (Suppl. I):73, 1992
25. Menzel HJ, Boerwinkle E, Schrangl-Will S, Utermann G: Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels. Hum Genet 79:368-372, 1988
26. Menzel HJ, Sigurdson G, Boerwinkle E, Schrangl-Will S, Dieplinger H, Utermann G: Frequency and effect of human apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population. Hum Genet 84:344-346, 1990
27. Chicaud P, Lambert D, Mejean E, Drouin P, Debry G: Comparative study of four HDE-cholesterol assay methods. Clin Chim Acta 116:55-62, 1981
28. Gambert P, Farnier M, Bouzerand C, Athias A, Lallemant C: Direct quantification of serum high density lipoprotein subfractions separated by gradient gel electrophoresis. Clin Chim Acta 172:183-190, 1988
29. Lagrost L, Gambert P, Meunier S, Morgado P, Desgres J, d'Athis P, Lallemant C: Correlation between apolipoprotein A-IV and triglyceride concentrations in human sera. J Lipid Res 30:701-710, 1989
30. Lagrost L, Gambert P, Boquillon M, Lallemant C: Evidence for high density lipoproteins as the major apolipoprotein A-IV containing fraction in normal human serum. J Lipid Res 30:1525-1534, 1989
31. Miyata Y, Koga S, Ibayashi H: Alterations in plasma levels of apolipoprotein A-IV in various clinical entities. Gastroenterol Jpn 21:479-485, 1986
32. Nestel PJ, Fidge NH, Tan MH: Increased lipoprotein-remnant formation in chronic renal failure. N Engl J Med 307:329-333, 1982
33. Weinberg RB, Spector MS: The self association of human apolipoprotein A-IV: evidence for an in vivo circulating dimeric form. J Biol Chem 260:14279-14286, 1985